Authors:
Knudsen, N
Christiansen, E
Brandt-Christensen, M
Nygaard, B
Perrild, H
Citation: N. Knudsen et al., Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretionbased on casual urine samples and comparison to 24h values, EUR J CL N, 54(4), 2000, pp. 361-363
Authors:
Nygaard, B
Jarlov, AE
Kristensen, LO
Faber, J
Citation: B. Nygaard et al., Serum levels of the cytokines IL-1 beta, IL-6 and ICAM-1 after I-131-treatment of Graves' disease and nodular goiter, HORMONE MET, 32(7), 2000, pp. 283-287
Authors:
Nygaard, B
Faber, J
Veje, A
Hegedus, L
Hansen, JM
Citation: B. Nygaard et al., Transition of nodular toxic goiter to autoimmune hyperthyroidism triggeredby I-131 therapy, THYROID, 9(5), 1999, pp. 477-481
Authors:
Harreby, M
Nygaard, B
Jessen, T
Larsen, E
Storr-Paulsen, A
Lindahl, A
Fisker, I
Laegaard, E
Citation: M. Harreby et al., Risk factors for low back pain in a cohort of 1389 Danish school children:an epidemiologic study, EUR SPINE J, 8(6), 1999, pp. 444-450
Authors:
Nygaard, B
Metcalfe, RA
Phipps, J
Weetman, AP
Hegedus, L
Citation: B. Nygaard et al., Graves' disease and thyroid associated ophthalmopathy triggered by I-131 treatment of non-toxic goiter, J ENDOC INV, 22(6), 1999, pp. 481-485
Authors:
Nygaard, B
Hegedus, L
Nielsen, KG
Ulriksen, P
Hansen, JM
Citation: B. Nygaard et al., Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules, CLIN ENDOCR, 50(2), 1999, pp. 197-202
Citation: L. Hegedus et al., Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?, J CLIN END, 84(2), 1999, pp. 756-760
Authors:
Laurberg, P
Nygaard, B
Glinoer, D
Grussendorf, M
Orgiazzi, J
Citation: P. Laurberg et al., Guidelines for TSH-receptor antibody measurements in pregnancy: results ofan evidence-based symposium organized by the European Thyroid Association, EUR J ENDOC, 139(6), 1998, pp. 584-586